A revolutionary breakthrough in cataract treatment is on the horizon, with the emergence of C-KAD, a new eye drop therapy.

Livionex, recently announced a successful end-of-Phase 2 meeting with the FDA, supporting the advancement of C-KAD, a 2.6% EDTA ophthalmic solution, to a Phase 3 clinical study. In an interview with ...

Costing a fraction of Leica, Panasonic, Nikon and Sony own-brand 85mm primes, the Meike 85mm f/1.8 Pro still offers full ...

If you were to tell me that at the beginning of the year, I would spend half of it going blind, having eye surgery and ...

An Independence woman, who doctors told would be partially blind for the rest of her life, is regaining her vision due to a ...

The human body contains a vast, complex, and interconnected web of organic tunnels and passageways that weave their way ...